emerging glp-1 gip treatments 2025 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 Pipeline Update: November 2025

Advancements in Drug Formulations Innovations in drug formulations are becoming a hallmark of the GLP-1 Drug Market

The shortage status of semaglutide has changed over time, and different forms may have different availability designations

In preclinical studies, PEG liposomes loaded with glial cell line-derived neurotrophic factor (GDNF) delivered via FUS markedly improved motor performance, illustrating the synergistic potential of combining nanomedicine with FUS-mediated BBB disruption [292]

This combination of fat mass breakdown and muscle support promotes a leaner body composition and contributes to achieving weight loss goals effectively

-